This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk00: Welcome to Vector Group LTD's fourth quarter 2022 earnings conference call. This call is being recorded and simultaneously webcast. An archived version of the webcast will be available at the investor relations section on the company's website located at www.vectorgroupltd.com for one year. During this call, the terms adjusted operating income adjusted net income from continuing operations, adjusted EBITDA from continuing operations, and tobacco adjusted operations income will be used. These terms are non-GAAP financial measures and should be considered in addition to, but not as a substitute for, other measures of financial performance prepared in accordance with GAAP. Reconciliation. on adjusted operating income from continuing operations, adjusted net income from continuing operations, adjusted EBITDA from continuing operations, and tobacco adjusted operating income are contained in the company's earning release, which has been posted on the investor relations section of the company's website. Before the call begins, I would like to read a safe harbor statement. The statements made during this conference call are not historical facts, are forward-looking statements that are subject to risk and uncertainties and could cause actual results to differ materially from those set forth in or applied by forward-looking statements. These risks are described in more detail on the company's Securities and Exchange Commission filings. Now I would like to turn the call over to the President and Chief Executive Officer of Vector Group, Howard Lorber. Please go ahead.
spk05: Good morning, and thank you for joining us for Vector Group's fourth quarter 2022 earnings conference call. With me today are Brian Kirkland, our Chief Financial Officer, and Nick Anson, President and Chief Operating Officer of Liggett Vector Brands. I will begin by reviewing Vector Group's consolidated financial results for the fourth quarter of 2022. Then I will ask Nick to summarize the performance of our tobacco business. I will close with final comments and open the call for questions. Before reviewing Vector Group's consolidated financial results, please note that because of the spinoff of Douglas Elliman in the fourth quarter of 2021, Douglas Elliman's financial results are presented as discontinued operations in Vector Group's consolidated financial statements for the 2021 period and are excluded from our adjusted results. First, beginning with Vector Group's consolidated balance sheet. Our balance sheet remains strong. As of December 31st, 2022, we maintained significant liquidity with cash and cash equivalents of approximately $225 million, including cash of $10 million at Liggett. We also held investment securities and long-term investments with a fair value of approximately $161 million. Turning to Vector Group's consolidated results from operations for the three months ended December 31st, 2022, Vector Group's revenues for the quarter were $363.8 million compared to $313.7 million in 2021. Net income attributed to Vector Group was $48.2 million or 30 cents per diluted share compared to $45.3 million or $0.29 per diluted common share in 2021. Net income attributed to Vector Group from continuing operations was $48.2 million or $0.30 per diluted common share, compared to $30.7 million or $0.20 per diluted common share in 2021. The company recorded adjusted EBITDA from continuing operations of $92.7 million compared to $84.3 million in 2021. Adjusting that income from continuing operations was $48.9 million, or $0.31 per diluted share, compared to $41.4 million, or $0.26 per diluted share in 2021. Next, Vector Group's consolidated results from operations for the year ended December 31, 2022. Vector Group's revenues for the year were $1.44 billion, compared to $1.22 billion in 2021. Net income attributed to Vector Group was $158.7 million, or $1.01 per diluted common share, compared to $219.5 million, or $1.40, diluted common share in 2021. Net income attributed to Vector Group from continuing operations was $158.7 million, or $0.01 per diluted common share, compared to $147.2 million, or 94 cents per diluted common share in 2021. The company recorded adjusted EBITDA from continuing operations of 352.2 million compared to 349.9 million in 2021. Adjusted net income from continuing operations was 153.4 million, or 97 cents per diluted share compared to $174.8 million, or $1.12, per diluted share in 2021. I will now turn it over to Nick to discuss our tobacco operations.
spk04: Nick? Thank you, Howard, and good morning. Liggett's performance remained strong during the fourth quarter of 2022 as we continued to capitalize on favorable marketplace opportunities and began to recognize the benefits of our investment in the Montego brand. Liggett's fourth quarter wholesale shipments increased by more than 15% and operating income increased by approximately 11% as we continued the transition of our Montego brand from volume growth to income growth. According to data from Management Science Associates, Liggett's retail shipments for the three months ended December 31, 2022, increased by 19.5% from the fourth quarter of 2021 driven by the significant growth of our Montego brand. Meanwhile, industry retail shipments declined by 9.3%. Liggett's fourth quarter retail market share increased to 5.8% up from 4.4% in the prior year period. This represents Liggett's largest market share since 1984 when we originally disrupted the tobacco industry by introducing discount cigarettes to the market. Our expertise in the discount category continues to be a core competency. Following a competitor's exit from the U.S. market in December 2021, we quickly capitalized on the opportunity and captured a significant portion of that competitor's 3% market share. In 2022, we converted more than 40% of that competitor's vacated business to Montego volume by leveraging our broad distribution base and strong retail sales execution. We believe our conversion percentage is the highest in the market and approximately twice as much as the next competitor. In addition, Liggett is the only major U.S. cigarette company to have increased unit volumes in the 10-year period ended December 31, 2022, a remarkable achievement given that industry volumes declined by approximately 34% during this period. Our long-term performance demonstrates the success of Liggett's mission to offer the best value propositions in the U.S. cigarette industry, and this strategy is proving particularly effective as more consumers shift to the discount segment as a result of current economic environment. According to Management Science Associates retail data for the three months ended December 31, 2022, the discount category represented 28.9% of the total market compared to 27.4% in the same period last year. Within the discount category, we continue to see momentum and growth for brands in the deep discount segment. For the fourth quarter of 2022, we estimate that the deep discount segment comprised 45% of the total discount category compared to 39% in the same period a year ago. We expect this migration to continue as the deep discount segment presents a more attractive price option for consumers. As such, we are confident that our value-focused brand portfolio, broad national distribution, and extensive experience in developing profitable discount brands provides Liget with a competitive advantage to meet shifting market demand. Montego, which became our largest brand in 2022, has also grown to become the second largest discount brand and fifth largest cigarette brand in the U.S. Our distribution of Montego expanded to 77,000 stores in the fourth quarter of 2022 compared to 50,000 stores in the fourth quarter of 2021. The brand's national retail market share increased to 3.2% in the final quarter of 2022, up from 2.8% in the third quarter of 2022, and from 1% in the fourth quarter of 2021. We estimate that Montego's share of the deep discount segment in the fourth quarter was approximately 24%, a significant expansion from its deep discount share of 10% in the prior year period. Our strategy with Montego is consistent with our long-term objective of optimizing profit by effectively managing volume, pricing, and market share in our value-based brand portfolio. While our investment in Montego expands our foundation for long-term earnings growth, we also continue to reap significant benefits from our income growth brands, Eagle 20s and Pyramid. Eagle 20s and Pyramid continue to deliver substantial income while also providing significant market presence. I will now turn to the combined tobacco financials for Liquor Group and Vector Tobacco. For the three months and year ended December 31st, 2022, revenues increased 18.6% to $363.8 million and 18.5% to a record of $1.43 billion, respectively, compared to $306.6 million and $1.2 billion in the respective 2021 periods. Tobacco operating income for the three months and year ended December 31st, 2022 was 93 million and 347 million respectively, compared to 83.8 million and 360.3 million in the respective 2021 periods. Tobacco adjusted EBITDA for the three months and year ended December 31st, 2022 were 94.5 million and 351.1 million respectively, compared to 85.5 million and 364.4 million in the respective 2021 periods. In the fourth quarter, we continue to see the benefits of our strategic investment in Montego, and this was reflected in our increased operating income as well as tobacco gross profit, which increased 10.5% from $105.2 million in the prior year period to $116.2 million in the fourth quarter of 2022. These high profits occurred as the current price gap between Montego and the industry's leading premium brand remained stable at approximately a 50% discount at retail. Consistent with previous brand expansions over the last 20 years, we expect to realize a significant return on our Montego investment as we move forward. As always, our investment decisions are based on thorough market analysis and adjusted in real time based on market circumstances and opportunities. this flexible investment approach remains our foundation for long-term earnings potential. In summary, the operational and financial performance of our tobacco business remains strong, and our historic retail market share gains validate our long-term profit growth strategy and the competitive advantage we have in the discount segment. Our strategy is underpinned by a broad distribution base, effective consumer-focused programs, and the scope and capabilities of our Salesforce. Most importantly, it builds on our foundation for long-term earnings potential. While we are always subject to industry, regulatory, and general market risk, we are confident we have the strategy and infrastructure in place to keep our business operating efficiently. Thanks for your attention, and back to you, Howard.
spk05: Thank you, Nick. Vector Group had an outstanding year in 2022. We are pleased with our longstanding practice of paying a quarterly cash dividend. It continues to be an important component of our capital allocation strategy and is our expectation that our policy will continue. Now, operator, please open the call for questions.
spk00: Absolutely. At this time, we will open the floor for questions. If you would like to ask a question, please press the star key followed by the one key on your touchtone phone now. Questions will be taken in the order in which they are received. If at any time you would like to remove yourself from the questioning queue, please press star two. Again, to ask a question, please press star one. We will take our first question from Ian Zaffino with Oppenheimer.
spk06: Thank you very much. Just getting in on Montego, What do we expect to spend to be going forward? You know, it seems like margins have come back So what should we expect from from spend and kind of margin outlook? As relates to kind of grow in that business.
spk04: Thank you So, you know as you know, we certainly don't provide specific guidance here, but you know look as we as we're transitioning the brand we are as always constantly analyzing the marketplace. As we start to take pricing based on our investment in our analytics, we are analyzing the market at a very granular level. And if we need to spend back, we will do so accordingly. So again, the objective, as I mentioned in my prepared remarks, is we're always looking to maximize the long-term profit, constantly analyzing the market and balancing between obviously volume growth and margin growth.
spk06: Okay. Thank you very much.
spk00: And our next question comes from Hale Holden with Barclays.
spk01: Just two questions. The first one is, I mean, you guys have done such a great job taking share in Liget. I was wondering if you were seeing any competitive response from the big majors potentially moving down into your price segment.
spk04: So, Hale, the simple answer to that is not to any significant degree. I think, you know, both Reynolds and Altria have indicated that that their focus remains on next-gen products and technologies. And I would say Altria specifically remains committed to being a premium company. So certainly Reynolds have made more recent forays into the discount segment with their relaunch of Lucky Strike at the end of 2020. But outside of their EDLP environment, the brand is not priced competitively to any significant degree to gain incremental volume. So in short, there's certainly no signs that the big tobacco companies are planning any significant strategic shift into the discount segment. So we remain the discount leader and feeling very good about where we are in the marketplace.
spk01: Great. And then my second question was, you know, as we sort of see margins move up from here a little bit, you're going to generate a significant amount of cash. And I was wondering if there had been any change to sort of capital allocation thoughts on free cash flow.
spk05: I don't think so. It's Howard Lover. I don't think so at this particular time, but we'll see. We want to return money to shareholders, so that's always one way to allocate some of this money we're making now in the new brands. But we're not going to do that right away. We want to really see and see how long we could continue to increase the price and still maintain the volume in our discount brands.
spk01: Great. Thank you, Howard. I appreciate it.
spk00: And our next question comes from Karu Martinson with Jefferies.
spk03: Good morning. Just on that cash question, when we look at third quarter, I think we were right around $500 million, and now it's kind of 3%. Mid-300s. Where did that cash get used? Did we buy back any bonds in the quarter?
spk02: No. Hey, good morning, Guru. How are you? I am well. Thank you. The Liggett pays the master settlement agreement payment in December, and the reduction in cash primarily related to that.
spk03: Okay. Thank you on that.
spk02: So it's working capitals.
spk03: Okay. And then when we look at now kind of call it three income brands in terms of Eagle, Pyramid, and Montego, should we think of this quarter here as kind of the new baseline given that there isn't all that much seasonality in the business?
spk04: Well, again, I would say since we don't provide specific guidance yet, You know, we, as I mentioned earlier, we are, you know, constantly analyzing the marketplace as we analyze our investment in Montego with the objective of maximizing long-term profit. We are constantly balancing, you know, volume, pricing, and share. And so we will make adjustments accordingly, and we do that at a very granular level. in various regions of the country to ensure that we are, you know, obviously maximizing volumes and ultimately to maximize profit for the long term.
spk03: Okay, and then just lastly, is there any update kind of on the regulatory challenges, whether it's, you know, California and menthol and our FDA and menthol, the Colorado litigation and or any other things that may have fallen past our radar?
spk04: You know, I don't think so. Let me take those individually. With respect to the California menthol ban, I would argue it's certainly too early to draw any conclusions. Certainly from an overall industry perspective, volumes have started out depressed, but certainly too early to draw any conclusions about smokers changing preferences. I would remind you that from our perspective, Liggett's menthol volumes in the state of California are less than half of 1% of our total volumes, though they are effectively immaterial to our total market share and earnings base. But overall, still too early to tell with respect to the California menthol ban. You know, the general proposed ban that the FDA That's still going through the multi-step rulemaking process. The FDA have indicated, and they continue to go through, what, about 175,000 comments on the menthol cigarette ban. So they've indicated that a final ruling will be issued later on in the year. At that point, it will be at least a year before it's implemented at retail, and that doesn't obviously account for potential litigation on the on the side of the industry. So no real changes with respect to that on the regulatory side. And Colorado, we're not moving forward any further with any of our litigation there. We feel confident that we've managed through that particular event in the marketplace and are feeling good about where we stand in Colorado at the moment. No significant updates on the regulatory side of things.
spk03: Thank you very much, guys. Appreciate it.
spk00: Ladies and gentlemen, those are all the questions we have for today. Thank you for joining us on Vector Group's quarterly earnings conference call. This will conclude our call. On behalf of all of us at Vector Group and Liget, we hope that everyone remains healthy and well. Thank you for your participation. You may now disconnect.
Disclaimer